Mirati Therapeutics’ $800 Million Common Stock Offering

Cooley LLP acted as counsel to Mirati Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Mirati Therapeutics, Inc., a San Diego-based late-stage…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here